Jan Staelens

422 citations
11 papers · 351 indexed · h-index 7
Topics
interferon and immune responses (3 papers)Immune Response and Inflammation (3 papers)Cytokine Signaling Pathways and Interactions (2 papers)

In The Last Decade

Jan Staelens

11 papers receiving 346 citations

Peers

Jan Staelens
Comparison fields: 5 of 61
  • Immunology 135
  • Molecular Biology 122
  • Genetics 87
  • Public Health, Environmental and Occupational Health 59
  • Hematology 46
Replace Mara Lennard Richard with:
Mara Lennard Richard United States
Jozef Goebels Belgium
Christelle Pérez France
Patricia Cavelier France
A. Lakshma Reddy United States
Birkir Þór Bragason Iceland
Sara Emelie Löfgren Brazil
Nikolai Netuschil Germany
G Kelényi Hungary
Jan Staelens relative to Mara Lennard Richard United States Mara Lennard Richard's profile →
Citations per field
00.5×3.9×
Mara Lennard Richard · 1×
Citations per year

Countries citing papers authored by Jan Staelens

Since Specialization
Citations

This map shows the geographic impact of Jan Staelens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Staelens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Staelens more than expected).

Fields of papers citing papers by Jan Staelens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Staelens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Staelens. The network helps show where Jan Staelens may publish in the future.

Co-authorship network of co-authors of Jan Staelens

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Staelens. A scholar is included among the top collaborators of Jan Staelens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Staelens. Jan Staelens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 33
2 66
3 3
4 73
5 1
6 56
7 5
8 13
9 32
10 2
11 67

About Jan Staelens

Jan Staelens is a scholar working on Immunology, Cancer Research and Pharmacology, having authored 11 papers that have together received 351 indexed citations. Recurring topics across this work include interferon and immune responses (3 papers), Immune Response and Inflammation (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Immunology (135 citations), Aquatic Science (37 citations) and Hematology (46 citations). Jan Staelens has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Claude Libert, Leen Puimège, Marnik Vuylsteke, Debbie Rombaut, Frans van Roy, John Benzie, Ilse Vercauteren, Brad J. Argue, J. L. Vaerman and Jean‐Louis Michaux. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026